Suppr超能文献

用硫唑嘌呤治疗组织细胞样Sweet综合征:一例报告

Histiocytoid Sweet syndrome treated with azathioprine: a case report.

作者信息

Miller Jonathan, Lee Nicole, Sami Naveed

机构信息

University of Alabama at Birmingham.

出版信息

Dermatol Online J. 2015 Jul 15;21(7):13030/qt0cg9m1h9.

Abstract

Histiocytoid Sweet syndrome (HSS) is a rare histologic variation of Sweet syndrome (SS) predominantly exhibiting mononuclear histiocytoid cells instead of neutrophils. We report a 22-year-old woman with HSS, who, after minimal improvement with colchicine and dapsone, had significant improvement of her cutaneous eruption and systemic symptoms following empiric treatment with azathioprine. Since azathioprine has historically been known to cause SS, this case highlights a previously unreported treatment response for the histiocytoid variant.

摘要

组织细胞样Sweet综合征(HSS)是Sweet综合征(SS)一种罕见的组织学变异型,主要表现为单核组织细胞样细胞而非中性粒细胞。我们报告了一名患有HSS的22岁女性,在使用秋水仙碱和氨苯砜治疗后症状改善甚微,而在经验性使用硫唑嘌呤治疗后,其皮肤皮疹和全身症状有显著改善。由于硫唑嘌呤历来被认为可引发SS,该病例凸显了一种此前未报道过的组织细胞样变异型的治疗反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验